Outcomes following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.

[1]  S. McGovern,et al.  Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma , 2019, Pediatric blood & cancer.

[2]  S. Donaldson,et al.  Increased local failure for patients with intermediate‐risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group , 2019, Cancer.

[3]  C. Esposito,et al.  Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy). , 2019, Current opinion in urology.

[4]  D. Chang,et al.  Risk of subsequent cancer diagnosis in patients treated with 3D conformal, intensity modulated, or proton beam radiation therapy. , 2019, Journal of Clinical Oncology.

[5]  S. Donaldson,et al.  Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. , 2019, International journal of radiation oncology, biology, physics.

[6]  G. Bisogno,et al.  Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome , 2018, Therapeutic advances in urology.

[7]  N. Cost,et al.  Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma , 2018, Current Urology Reports.

[8]  C. Haie-meder,et al.  Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma. , 2017, International journal of radiation oncology, biology, physics.

[9]  J. Thüroff,et al.  Erectile function after treatment for rhabdomyosarcoma of prostate and bladder. , 2016, Journal of pediatric urology.

[10]  A. Schuck,et al.  Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial , 2016, Annals of Surgical Oncology.

[11]  P. Mckenna,et al.  Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma , 2016, International Urology and Nephrology.

[12]  James R. Anderson,et al.  Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group. , 2015, International journal of radiation oncology, biology, physics.

[13]  A. Niemierko,et al.  Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. , 2015, International journal of radiation oncology, biology, physics.

[14]  N. Tarbell,et al.  A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  C. Haie-meder,et al.  Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: Results from International Society of Paediatric Oncology (SIOP) studies: Malignant mesenchymal tumour (MMT) 84, 89 and 95 , 2014, Pediatric blood & cancer.

[16]  S. Wolden,et al.  Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. , 2014, The Journal of urology.

[17]  M. Stevens,et al.  Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Zhengjia Chen,et al.  Radiation therapy target volume reduction in pediatric rhabdomyosarcoma , 2013, Cancer.

[19]  S. Lane,et al.  What is the evidence for radical surgery in the management of localized embryonal bladder/prostate rhabdomyosarcoma? , 2012, Pediatric blood & cancer.

[20]  N. Tarbell,et al.  Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. , 2011, International journal of radiation oncology, biology, physics.

[21]  D. Thorwarth,et al.  Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery , 2011, Strahlentherapie und Onkologie.

[22]  A. Schuck,et al.  Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma trial CWS‐96 , 2011, Pediatric blood & cancer.

[23]  D. Rodeberg,et al.  Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  James R. Anderson,et al.  Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. , 2006, The Journal of urology.

[25]  D. Rodeberg,et al.  Significance of Persistent Mature Rhabdomyoblasts in Bladder/Prostate Rhabdomyosarcoma: Results From IRS IV , 2006, Journal of pediatric hematology/oncology.

[26]  James R. Anderson,et al.  Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Hudson,et al.  Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Donaldson,et al.  Results of treatment of fifty‐six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: A report from The Intergroup Rhabdomyosarcoma Study‐IV, 1991–1997 , 2004, Pediatric blood & cancer.

[29]  F. Ullrich,et al.  Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. , 2004, The Journal of urology.

[30]  R. Hohenfellner,et al.  Rhabdomyosarcoma of the bladder, prostate or vagina: the role of surgery , 2004, BJU international.

[31]  E. Gehan,et al.  The Third Intergroup Rhabdomyosarcoma Study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Pritchard,et al.  Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. , 1994, British Journal of Cancer.

[33]  R. Heyn,et al.  Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the intergroup rhabdomyosarcoma study committee , 1993, Cancer.

[34]  Gonsette Re.  Advances in ventriculography and myelography with the non-ionic constrast medium metrizamide. , 1975 .